Highlights
The global Computer-aided Detection (CAD) for Breast Cancer Screening market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Computer-aided Detection (CAD) for Breast Cancer Screening is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Computer-aided Detection (CAD) for Breast Cancer Screening is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Computer-aided Detection (CAD) for Breast Cancer Screening in Clinics is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Computer-aided Detection (CAD) for Breast Cancer Screening include CureMetrix, Inc., FUJIFILM Corporation, GE Healthcare, Hitachi, Ltd., Hologic, Inc., iCAD Inc., IMS Giotto SpA, Konica Minolta and McKesson Corporation, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Computer-aided Detection (CAD) for Breast Cancer Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computer-aided Detection (CAD) for Breast Cancer Screening.
The Computer-aided Detection (CAD) for Breast Cancer Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Computer-aided Detection (CAD) for Breast Cancer Screening market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Computer-aided Detection (CAD) for Breast Cancer Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
CureMetrix, Inc.
FUJIFILM Corporation
GE Healthcare
Hitachi, Ltd.
Hologic, Inc.
iCAD Inc.
IMS Giotto SpA
Konica Minolta
McKesson Corporation
Merge Healthcare (IBM Corporation)
Neusoft Corporation
Qlarity Imaging, LLC
Siemens Healthineers AG
Segment by Type
Mammography CAD
MRI CAD
PET/CT CAD
Ultrasound CAD
Segment by Application
Clinics
Hospital
Medical Examination Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Computer-aided Detection (CAD) for Breast Cancer Screening companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Mammography CAD
1.2.3 MRI CAD
1.2.4 PET/CT CAD
1.2.5 Ultrasound CAD
1.3 Market by Application
1.3.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Clinics
1.3.3 Hospital
1.3.4 Medical Examination Center
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Market Perspective (2018-2029)
2.2 Computer-aided Detection (CAD) for Breast Cancer Screening Growth Trends by Region
2.2.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Computer-aided Detection (CAD) for Breast Cancer Screening Historic Market Size by Region (2018-2023)
2.2.3 Computer-aided Detection (CAD) for Breast Cancer Screening Forecasted Market Size by Region (2024-2029)
2.3 Computer-aided Detection (CAD) for Breast Cancer Screening Market Dynamics
2.3.1 Computer-aided Detection (CAD) for Breast Cancer Screening Industry Trends
2.3.2 Computer-aided Detection (CAD) for Breast Cancer Screening Market Drivers
2.3.3 Computer-aided Detection (CAD) for Breast Cancer Screening Market Challenges
2.3.4 Computer-aided Detection (CAD) for Breast Cancer Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Computer-aided Detection (CAD) for Breast Cancer Screening Players by Revenue
3.1.1 Global Top Computer-aided Detection (CAD) for Breast Cancer Screening Players by Revenue (2018-2023)
3.1.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Revenue Market Share by Players (2018-2023)
3.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Computer-aided Detection (CAD) for Breast Cancer Screening Revenue
3.4 Global Computer-aided Detection (CAD) for Breast Cancer Screening Market Concentration Ratio
3.4.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Computer-aided Detection (CAD) for Breast Cancer Screening Revenue in 2022
3.5 Computer-aided Detection (CAD) for Breast Cancer Screening Key Players Head office and Area Served
3.6 Key Players Computer-aided Detection (CAD) for Breast Cancer Screening Product Solution and Service
3.7 Date of Enter into Computer-aided Detection (CAD) for Breast Cancer Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Computer-aided Detection (CAD) for Breast Cancer Screening Breakdown Data by Type
4.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Historic Market Size by Type (2018-2023)
4.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Forecasted Market Size by Type (2024-2029)
5 Computer-aided Detection (CAD) for Breast Cancer Screening Breakdown Data by Application
5.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Historic Market Size by Application (2018-2023)
5.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Computer-aided Detection (CAD) for Breast Cancer Screening Market Size (2018-2029)
6.2 North America Computer-aided Detection (CAD) for Breast Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Computer-aided Detection (CAD) for Breast Cancer Screening Market Size by Country (2018-2023)
6.4 North America Computer-aided Detection (CAD) for Breast Cancer Screening Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Computer-aided Detection (CAD) for Breast Cancer Screening Market Size (2018-2029)
7.2 Europe Computer-aided Detection (CAD) for Breast Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Computer-aided Detection (CAD) for Breast Cancer Screening Market Size by Country (2018-2023)
7.4 Europe Computer-aided Detection (CAD) for Breast Cancer Screening Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Computer-aided Detection (CAD) for Breast Cancer Screening Market Size (2018-2029)
8.2 Asia-Pacific Computer-aided Detection (CAD) for Breast Cancer Screening Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Computer-aided Detection (CAD) for Breast Cancer Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific Computer-aided Detection (CAD) for Breast Cancer Screening Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Computer-aided Detection (CAD) for Breast Cancer Screening Market Size (2018-2029)
9.2 Latin America Computer-aided Detection (CAD) for Breast Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Computer-aided Detection (CAD) for Breast Cancer Screening Market Size by Country (2018-2023)
9.4 Latin America Computer-aided Detection (CAD) for Breast Cancer Screening Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Computer-aided Detection (CAD) for Breast Cancer Screening Market Size (2018-2029)
10.2 Middle East & Africa Computer-aided Detection (CAD) for Breast Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Computer-aided Detection (CAD) for Breast Cancer Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa Computer-aided Detection (CAD) for Breast Cancer Screening Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CureMetrix, Inc.
11.1.1 CureMetrix, Inc. Company Detail
11.1.2 CureMetrix, Inc. Business Overview
11.1.3 CureMetrix, Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.1.4 CureMetrix, Inc. Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2018-2023)
11.1.5 CureMetrix, Inc. Recent Development
11.2 FUJIFILM Corporation
11.2.1 FUJIFILM Corporation Company Detail
11.2.2 FUJIFILM Corporation Business Overview
11.2.3 FUJIFILM Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.2.4 FUJIFILM Corporation Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2018-2023)
11.2.5 FUJIFILM Corporation Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Detail
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.3.4 GE Healthcare Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2018-2023)
11.3.5 GE Healthcare Recent Development
11.4 Hitachi, Ltd.
11.4.1 Hitachi, Ltd. Company Detail
11.4.2 Hitachi, Ltd. Business Overview
11.4.3 Hitachi, Ltd. Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.4.4 Hitachi, Ltd. Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2018-2023)
11.4.5 Hitachi, Ltd. Recent Development
11.5 Hologic, Inc.
11.5.1 Hologic, Inc. Company Detail
11.5.2 Hologic, Inc. Business Overview
11.5.3 Hologic, Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.5.4 Hologic, Inc. Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2018-2023)
11.5.5 Hologic, Inc. Recent Development
11.6 iCAD Inc.
11.6.1 iCAD Inc. Company Detail
11.6.2 iCAD Inc. Business Overview
11.6.3 iCAD Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.6.4 iCAD Inc. Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2018-2023)
11.6.5 iCAD Inc. Recent Development
11.7 IMS Giotto SpA
11.7.1 IMS Giotto SpA Company Detail
11.7.2 IMS Giotto SpA Business Overview
11.7.3 IMS Giotto SpA Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.7.4 IMS Giotto SpA Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2018-2023)
11.7.5 IMS Giotto SpA Recent Development
11.8 Konica Minolta
11.8.1 Konica Minolta Company Detail
11.8.2 Konica Minolta Business Overview
11.8.3 Konica Minolta Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.8.4 Konica Minolta Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2018-2023)
11.8.5 Konica Minolta Recent Development
11.9 McKesson Corporation
11.9.1 McKesson Corporation Company Detail
11.9.2 McKesson Corporation Business Overview
11.9.3 McKesson Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.9.4 McKesson Corporation Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2018-2023)
11.9.5 McKesson Corporation Recent Development
11.10 Merge Healthcare (IBM Corporation)
11.10.1 Merge Healthcare (IBM Corporation) Company Detail
11.10.2 Merge Healthcare (IBM Corporation) Business Overview
11.10.3 Merge Healthcare (IBM Corporation) Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.10.4 Merge Healthcare (IBM Corporation) Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2018-2023)
11.10.5 Merge Healthcare (IBM Corporation) Recent Development
11.11 Neusoft Corporation
11.11.1 Neusoft Corporation Company Detail
11.11.2 Neusoft Corporation Business Overview
11.11.3 Neusoft Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.11.4 Neusoft Corporation Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2018-2023)
11.11.5 Neusoft Corporation Recent Development
11.12 Qlarity Imaging, LLC
11.12.1 Qlarity Imaging, LLC Company Detail
11.12.2 Qlarity Imaging, LLC Business Overview
11.12.3 Qlarity Imaging, LLC Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.12.4 Qlarity Imaging, LLC Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2018-2023)
11.12.5 Qlarity Imaging, LLC Recent Development
11.13 Siemens Healthineers AG
11.13.1 Siemens Healthineers AG Company Detail
11.13.2 Siemens Healthineers AG Business Overview
11.13.3 Siemens Healthineers AG Computer-aided Detection (CAD) for Breast Cancer Screening Introduction
11.13.4 Siemens Healthineers AG Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening Business (2018-2023)
11.13.5 Siemens Healthineers AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
CureMetrix, Inc.
FUJIFILM Corporation
GE Healthcare
Hitachi, Ltd.
Hologic, Inc.
iCAD Inc.
IMS Giotto SpA
Konica Minolta
McKesson Corporation
Merge Healthcare (IBM Corporation)
Neusoft Corporation
Qlarity Imaging, LLC
Siemens Healthineers AG
听
听
*If Applicable.
